Bank Hapoalim BM’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $262K | Buy |
1,073
+100
| +10% | +$23.3K | 0.04% | 97 |
|
|
2025
Q4 | $201K | Buy |
+973
| New | +$192K | 0.02% | 107 |
|
|
2024
Q4 | – | Sell |
-1,469
| Closed | -$238K | – | 128 |
|
|
2024
Q3 | $238K | Sell |
1,469
-167
| -10% | -$26.6K | 0.04% | 124 |
|
|
2024
Q2 | $239K | Sell |
1,636
-40
| -2% | -$5.95K | 0.03% | 129 |
|
|
2024
Q1 | $265K | Sell |
1,676
-135
| -7% | -$21.5K | 0.03% | 128 |
|
|
2023
Q4 | $284K | Sell |
1,811
-1,060
| -37% | -$163K | 0.04% | 132 |
|
|
2023
Q3 | $447K | Sell |
2,871
-1,667
| -37% | -$275K | 0.07% | 108 |
|
|
2023
Q2 | $751K | Sell |
4,538
-930
| -17% | -$150K | 0.11% | 112 |
|
|
2023
Q1 | $848K | Sell |
5,468
-1,971
| -26% | -$318K | 0.12% | 109 |
|
|
2022
Q4 | $1.31M | Sell |
7,439
-240
| -3% | -$41.4K | 0.16% | 83 |
|
|
2022
Q3 | $1.25M | Buy |
7,679
+936
| +14% | +$158K | 0.16% | 91 |
|
|
2022
Q2 | $1.2M | Sell |
6,743
-646
| -9% | -$115K | 0.15% | 99 |
|
|
2022
Q1 | $1.31M | Sell |
7,389
-192
| -3% | -$32.7K | 0.14% | 108 |
|
|
2021
Q4 | $1.3M | Sell |
7,581
-409
| -5% | -$67K | 0.13% | 117 |
|
|
2021
Q3 | $1.29M | Sell |
7,990
-99
| -1% | -$16.9K | 0.13% | 113 |
|
|
2021
Q2 | $1.33M | Sell |
8,089
-3,061
| -27% | -$507K | 0.15% | 111 |
|
|
2021
Q1 | $1.83M | Buy |
11,150
+153
| +1% | +$24.8K | 0.23% | 85 |
|
|
2020
Q4 | $1.73M | Buy |
10,997
+1,577
| +17% | +$233K | 0.24% | 75 |
|
|
2020
Q3 | $1.4K | Sell |
9,420
-3,801
| -29% | -$562K | 0.07% | 69 |
|
|
2020
Q2 | $1.86M | Buy |
13,221
+600
| +5% | +$87.4K | 0.44% | 53 |
|
|
2020
Q1 | $1.66M | Sell |
12,621
-858
| -6% | -$122K | 0.52% | 44 |
|
|
2019
Q4 | $1.97M | Sell |
13,479
-36
| -0.3% | -$4.88K | 0.43% | 49 |
|
|
2019
Q3 | $1.74M | Sell |
13,515
-1,890
| -12% | -$249K | 0.43% | 46 |
|
|
2019
Q2 | $2.15M | Buy |
15,405
+205
| +1% | +$28.4K | 0.53% | 40 |
|
|
2019
Q1 | $2.13M | Buy |
15,200
+1,555
| +11% | +$208K | 0.51% | 44 |
|
|
2018
Q4 | $1.76M | Buy |
13,645
+7,288
| +115% | +$1.02M | 0.57% | 39 |
|
|
2018
Q3 | $878K | Buy |
6,357
+1,757
| +38% | +$233K | 0.21% | 82 |
|
|
2018
Q2 | $558K | Buy |
4,600
+1,442
| +46% | +$180K | 0.15% | 118 |
|
|
2018
Q1 | $405K | Sell |
3,158
-199
| -6% | -$26.9K | 0.11% | 132 |
|
|
2017
Q4 | $469 | Sell |
3,357
-136
| -4% | -$18.9K | 0.1% | 133 |
|
|
2017
Q3 | $454K | Buy |
3,493
+120
| +4% | +$15.9K | 0.1% | 146 |
|
|
2017
Q2 | $446K | Sell |
3,373
-500
| -13% | -$63.8K | 0.11% | 137 |
|
|
2017
Q1 | $482K | Buy |
3,873
+566
| +17% | +$67.6K | 0.11% | 125 |
|
|
2016
Q4 | $381K | Buy |
3,307
+226
| +7% | +$26.1K | 0.1% | 133 |
|
|
2016
Q3 | $364K | Sell |
3,081
-653
| -17% | -$79.2K | 0.09% | 147 |
|
|
2016
Q2 | $453K | Buy |
3,734
+470
| +14% | +$53.4K | 0.11% | 124 |
|
|
2016
Q1 | $353K | Buy |
3,264
+1,162
| +55% | +$120K | 0.08% | 124 |
|
|
2015
Q4 | $216K | Sell |
2,102
-90
| -4% | -$9.05K | 0.05% | 152 |
|
|
2015
Q3 | $205K | Buy |
+2,192
| New | +$212K | 0.05% | 147 |
|
Other funds holding JNJ
VCM
VPM
Bank Hapoalim BM's JNJ Position: Q1 2026 in Review
Bank Hapoalim BM increased its Johnson & Johnson (JNJ) stake by 10% in Q1 2026, buying an estimated $23.3K and bringing the position to 1,073 shares worth $262K. The position accounts for 0.04% of the portfolio, ranked #97.
Bank Hapoalim BM first reported a position in JNJ in Q3 2015 and has held it in 39 quarters since. The position peaked at $2.15M in Q2 2019. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Bank Hapoalim BM held 1,073 shares of Johnson & Johnson worth $262K as of Q1 2026.
- Bank Hapoalim BM bought 100 Johnson & Johnson shares in Q1 2026, an estimated $23.3K.
- Johnson & Johnson made up 0.04% of Bank Hapoalim BM's portfolio in Q1 2026, its #97 holding.
- Bank Hapoalim BM first reported a position in Johnson & Johnson in Q3 2015 and has held it in 39 quarters since.
- Bank Hapoalim BM's Johnson & Johnson position peaked at $2.15M in Q2 2019.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Bank Hapoalim BM's 13F filing for Q1 2026, filed 4 May 2026.